[1]李 璇 文 彬 黄 婷.中医治疗艾滋病免疫功能重建不良研究进展[J].大众科技,2021,23(3):43-45.
 Research Progress of Traditional Chinese Medicine in the Treatment of AIDS Immunodeficiency Reconstruction[J].Popular Science & Technology,2021,23(3):43-45.
点击复制

中医治疗艾滋病免疫功能重建不良研究进展()
分享到:

《大众科技》[ISSN:1008-1151/CN:45-1235/N]

卷:
23
期数:
2021年3
页码:
43-45
栏目:
医药与卫生
出版日期:
2021-03-20

文章信息/Info

Title:
Research Progress of Traditional Chinese Medicine in the Treatment of AIDS Immunodeficiency Reconstruction
作者:
李 璇 文 彬 黄 婷
(广西中医药大学附属瑞康医院,广西 南宁 530011)
关键词:
艾滋病中医药高效抗反转录病毒治疗免疫功能重建不良
Keywords:
AIDS traditional Chinese medicine HAART immunodeficiency reconstruction
文献标志码:
A
摘要:
免疫功能重建不良仍是目前艾滋病治疗亟待解决的重点、难点问题。现代医学除了HAART治疗方案之外,还没有令人信服的具体干预措施。而中医药治疗艾滋病免疫功能重建不良具有明显的优势,主要体现在提高患者CD4+T淋巴细胞水平、改善临床症状、提高生存质量以及稳定的安全性。文章对近年来中医药治疗艾滋病免疫功能重建不良研究进展进行梳理,以期为今后进一步研究提供参考。
Abstract:
Immunodeficiency reconstruction is still a key and difficult problem in the treatment of AIDS. In addition to HAART treatment, there is no convincing intervention in modern medicine. Traditional Chinese medicine has obvious advantages in the treatment of immunodeficiency reconstruction of AIDS, mainly reflected in the improvement of patients CD4+T lymphocyte level, improve clinical symptoms, improve the quality of life and stable safety. This article reviews the research progress of traditional Chinese medicine in the treatment of immunodeficiency reconstruction of AIDS in recent years, in order to provide reference for further research in the future.

参考文献/References:

[1] Pinzone M R, Di R M, Cacopardo B, et al. HIV RNA suppression and immune restoration: can we do better?[J]. Clinical and Developmental Immunology, 2012, 2012: 515962. [2] Montaner J S G, Lima V D, Harrigan P R, et al. Expansion of HAART Coverage Is Associated with Sustained Decreases in HIV/AIDS Morbidity, Mortality and HIV Transmission: The “HIV Treatment as Prevention” Experience in a Canadian Setting[J]. PLOS ONE, 2014, 9(2): e87872. [3] Engsig F, Gerstoft J, Kronborg G, et al. Long-term mortality in HIV patients virally suppressed for more than three years with incomplete CD4 recovery: A cohort study[J]. BMC Infectious Dseases, 2010, 10: 318. [4] Acheco Y M, Jarrin I, Rosado I, et al. Increased risk of non-AIDS-related events in HIV subjects with persistent low CD4 counts despite cART in the CoRIS cohort[J]. Antiviral Research, 2015, 117: 69-74. [5] Gaardbo J C, Hartling H J, Gerstoft J, et al. Incomplete Immune Recovery in HIV Infection: Mechanisms, Relevance for Clinical Care, and Possible Solutions[J]. Clinical and Developmental Immunlogy, 2012, 183(9): 1328-1335. [6] Onwumeh J, Okwundu C I, Kredo T, et al. Interleukin-2 as an adjunct to antiretroviral therapy for HIV-positive adults[J]. CEochrane Database of Systematic Reviews, 2017, 5: CD009818. [7] Thiebaut R, Jarne A, Routy J P, et al. Repeated Cycles of Recombinant Human Interleukin 7 in HIV-Infected Patients With Low CD4 T-Cell Reconstitution on Antiretroviral Therapy: Results of 2 Phase II Multicenter Studies[J]. Clincal Infectious Diseases, 2016, 62(9): 1178-1185. [8] Gharakhanian S, Katlama C, Launey O, et al. VAC-3S, an Immunoprotective HIV Vaccine Directed to the 3S Motif of gp41, in Patients Receiving ART: Safety, Dose and Immunization Schedule Assessment[J]. AIDS Reaearch and Human Retrpvoruses, 2013, 29(11): A156-A156. [9] 杨巧丽,郑好飞,刘颖. 温肾法与艾滋病中晚期患者的免疫重建[J]. 中医杂志,2016,57(18): 1614-1615. [10] 王丹妮,陈秀敏,蒋自强,等. 湿邪与艾滋病免疫功能低下的相关性探讨[J]. 中华中医药杂志,2012,27(12): 3038-3040. [11] 中华中医药学会防治艾滋病分会. 艾滋病免疫功能重建不良中西医协同治疗专家共识[J]. 中医学报,2020,35(2): 281-284. [12] Li T, Xie J, Li Y, et al. Tripterygium wilfordii Hook F extract in cART-treated HIV patients with poor immune response: a pilot study to assess its immunomodulatory effects and safety[J]. HIV Clinical Trials, 2015, 16(2): 49-56. [13] 张绿浪,陈思源,邓长刚,等. 雷公藤治疗对艾滋病患者CD4+T淋巴细胞及炎症因子水平的影响[J]. 川北医学院学报,2018,33(5): 748-751. [14] 陆鹏,莫让辉,梁柱石. 黄芪对免疫无应答艾滋病患者CD4+T淋巴细胞数的影响[J]. 中华实验和临床感染病杂志,2014,8(2): 108-109. [15] 刘震,王阶,林洪生,等. 中药免疫2号方对艾滋病患者免疫重建的研究[J]. 中国中药杂志,2013,38(15): 2458-2462. [16] 王阶,林洪生,李勇,等. 免疫2号方对艾滋病免疫重建不全患者临床症状、体征的影响[J]. 中医杂志,2012,53(11): 923-926. [17] 赵霞,谢正兰,李铁. 加用益气补肾方对艾滋病免疫重建不全患者免疫功能的影响[J]. 广西中医药,2014,37(3): 36-38. [18] 赵权,罗向群,徐奎,等. 自拟健脾益气方联合HARRT促进脾虚湿盛证型免疫重建不良艾滋病患者免疫重建的临床研究[J]. 中华医学,2018,10(30): 102-105. [19] 咸庆飞,刘颖,邹雯,等. 温肾健脾颗粒对HAART后免疫重建不全艾滋病患者T淋巴细胞亚群的作用研究[J]. 中国中医基础医学杂志,2019,25(10): 1391-1455. [20] 杨玉琪,瞿广城,陆中云,等. 扶正抗毒丸联合HAART治疗艾滋病免疫重建不全的临床疗效分析[J]. 中医药导报,2020,26(10): 66-68. [21] 苏琛,彭鑫,刘晶晶. 培元胶囊联合HAART对艾滋病免疫重建不良的临床观察[J]. 中国艾滋病性病,2020,26(1): 19-22. [22] 毛宇湘,李宝印,路聚更,等. 中药配合艾灸治疗HIV/AIDS的临床研究[J]. 中医学报,2012,27(1): 1-3. [23] 王庆雷,路聚更,李中堂,等. 艾灸结合中医药辨证论治对艾滋病中CD4的影响[J]. 中医药导报,2012,18(6): 57-58. [24] 李璇,黄婷,文彬,等. 壮药穴位贴敷配合HAART对30例老年艾滋病免疫重建不良病人疗效分析[J]. 中国艾滋病性病,2020,26(7): 753-756. [25] 汤艳莉,王阶,李勇,等. 艾滋病免疫重建不全患者Toll样受体信号传导通路改变及免疫2号方干预的影响[J]. 中华中医药杂志,2012,27(4): 789-793. [26] 邹雯,王健,高建国,等. 益气健脾颗粒联合HAART治疗对艾滋病免疫无应答患者TLR4和TLR9的影响[J]. 中华中医药杂志,2019,34(9): 4426-4428. [27] 邹雯,王健,刘颖,等. 中药联合HAART治疗对艾滋病免疫功能重建不全患者TLR相关基因mRNA水平的影响[J]. 中华中医药杂志,2017,32(12): 5672-5674. [28] 朱海鹏,郑玉宝,曹焕焕,等. HAART治疗下HIV感染者Th17/Treg的平衡及其与T细胞增殖、活化的相关性研究[J]. 热带医学杂志,2014,14(7): 859-863. [29] 张曼,芮宝玲,沈弢,等. 静脉吸毒HIV-1感染者Th17/Treg失衡与疾病进展及单核细胞活化水平的相关性研究[J]. 中国病毒病杂志,2013,3(5): 330-334. [30] 陈昕,朱铭凤,周成鹏,等. 从Th17/Treg平衡探究中医两重外治法联合HAART对艾滋病免疫重建不良的影响[J]. 中国艾滋病性病,2019,25(8): 776-778.

相似文献/References:

[1]李瑞祥 陈斯宁.中医药对 COPD 大鼠模型作用机理的研究进展[J].大众科技,2014,16(05):95.
[2]廖咸硕.慢性乙型肝炎中医药治疗进展[J].大众科技,2014,16(10):124.
 Progress in the treatment of chronic hepatitis B with traditional Chinese medicine[J].Popular Science & Technology,2014,16(3):124.
[3]李鹏程 韦艾凌 张永琴 唐秋媛.中医药调控肝癌血管生成的研究近况[J].大众科技,2014,16(11):136.
 Research status on traditional Chinese medicine of angiogenesis inhepatocellular carcinoma[J].Popular Science & Technology,2014,16(3):136.
[4]万 媛.中医药协同治疗卒中后抑郁症的研究近况[J].大众科技,2014,16(12):98.
 The recent clinical research of Chinese-western therapy on post-stroke depression[J].Popular Science & Technology,2014,16(3):98.
[5]杨 赟 梁爱武.中医药对慢性阻塞性肺疾病MMP-9、TIMP-1 影响的研究进展[J].大众科技,2015,15(02):78.
 慢性阻塞性肺疾病;基质金属蛋白酶-9;金属蛋白酶组织抑制-1;气道重塑;中医药[J].Popular Science & Technology,2015,15(3):78.
[6]张艳娟,吴 光.中医药院校助力精准扶贫工作研究——以广西中医药大学定点扶贫为例[J].大众科技,2019,21(09):129.
 Research on Targeted Poverty Alleviation Work in Colleges and Universities of Traditional Chinese Medicine ——Take Guangxi University of Traditional Chinese Medicine as an Example[J].Popular Science & Technology,2019,21(3):129.
[7]陈曹华 李沛桢 周华亮 马潍珩 刘汝专.中医药治疗腰椎间盘突出症术后残留症状的研究进展[J].大众科技,2022,24(06):112.
 Research Status of Postoperative Residual Symptoms of Lumbar Intervertebral Disc Herniation Treated with Traditional Chinese Medicine[J].Popular Science & Technology,2022,24(3):112.
[8]桂雄斌 伏广虎.中医药治疗变应性鼻炎研究进展[J].大众科技,2018,20(06):61.
[9]韦卓 伍燕宏 郑景辉.血府逐瘀汤治疗心血管病的研究进展[J].大众科技,2018,20(06):63.
[10]兰鹏潘凤仙苏锦勋.脑卒中后肩手综合征的中医药外治法研究进展[J].大众科技,2018,20(06):71.
[11]刘振威 相惠君 赵晓芳.中医药干预HIV感染者肠道菌群失调的思路与方法[J].大众科技,2022,24(05):79.
 Thoughts and Methods of Traditional Chinese Medicine Intervention on Intestinal Flora Imbalance of HIV Infected Persons[J].Popular Science & Technology,2022,24(3):79.

备注/Memo

备注/Memo:
【收稿日期】2021-01-05 【基金项目】国家“十三五”科技重大传染病专项(2017ZX10205502001007,2018ZX10715008004);广西科技攻关课题(桂科AB19110031);广西中医药局自筹课题(GZZC2020116);中西医结合广西一流学科培育课题(2019XK160,2019XK162);广西特聘专家团队、广西高发传染病中西医结合转化医学重点实验室资助;广西中医药适宜技术开发与推广项目(GZSY21-38)。 【作者简介】李璇(1982-),女,广西人,广西中医药大学附属瑞康医院副主任医师,硕士,研究方向为中西医结合治疗艾滋病。
更新日期/Last Update: 2021-06-02